Drugs that contain Sumatriptan
1. Imitrex patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5307953 | GLAXOSMITHKLINE | Single dose dispenser having a piercing member |
Dec, 2012
(11 years ago) | |
|
US5307953 (Pediatric) | GLAXOSMITHKLINE | Single dose dispenser having a piercing member |
Jun, 2013
(10 years ago) | |
| US5554639 | GLAXOSMITHKLINE | Medicaments |
Sep, 2013
(10 years ago) | |
|
US5554639 (Pediatric) | GLAXOSMITHKLINE | Medicaments |
Mar, 2014
(10 years ago) | |
Market Authorisation Date: 26 August, 1997
Treatment: Method of treating migraine
Dosage: SPRAY;NASAL
More Information on Dosage
IMITREX family patents
2. Tosymra patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8440631 | TONIX MEDS | Compositions for drug administration |
May, 2026
(2 years from now) | |
| US8268791 | TONIX MEDS | Alkylglycoside compositions for drug administration |
May, 2026
(2 years from now) | |
| US9283280 | TONIX MEDS | Compositions for drug administration |
May, 2026
(2 years from now) | |
| US9974770 | TONIX MEDS | Formulations comprising triptan compounds |
Jun, 2030
(6 years from now) | |
| US9610280 | TONIX MEDS | Formulations comprising triptan compounds |
Jun, 2030
(6 years from now) | |
| US10603305 | TONIX MEDS | Formulations comprising triptan compounds |
Jun, 2030
(6 years from now) | |
| US11337962 | TONIX MEDS | Formulations comprising triptan compounds |
Jun, 2030
(6 years from now) | |
| US9211282 | TONIX MEDS | Formulations comprising triptan compounds |
Jul, 2031
(7 years from now) | |
Market Authorisation Date: 25 January, 2019
Treatment: Acute treatment of migraine
Dosage: SPRAY;NASAL
More Information on Dosage
TOSYMRA family patents